{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:34:07Z","timestamp":1765294447202},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1711,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1038\/ki.2010.387","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T12:45:08Z","timestamp":1287578708000},"page":"702-707","source":"Crossref","is-referenced-by-count":49,"title":["New Vitamin D analogs and changing therapeutic paradigms"],"prefix":"10.1016","volume":"79","author":[{"given":"John","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zehnder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.387_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.387_bb0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","article-title":"Meta-analysis: vitamin D compounds in chronic kidney disease","volume":"147","author":"Palmer","year":"2007","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1038\/ki.2010.387_bb0020","article-title":"Vitamin D compounds for people with chronic kidney disease not requiring dialysis","volume":"CD008175","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1038\/ki.2010.387_bb0025","article-title":"Vitamin D compounds for people with chronic kidney disease requiring dialysis","volume":"CD005633","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1038\/ki.2010.387_bb0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJM197211022871801","article-title":"Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man","volume":"287","author":"Brickman","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.387_bb0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","article-title":"The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion","volume":"84","author":"Brown","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.387_bb0040","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1053\/ajkd.1998.v32.pm9808142","article-title":"Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats","volume":"32","author":"Slatopolsky","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.387_bb0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10157-005-0363-x","article-title":"Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients","volume":"9","author":"Tamura","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/ki.2010.387_bb0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1744-9987.2007.00422.x","article-title":"Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism","volume":"11","author":"Ogata","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1038\/ki.2010.387_bb0055","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.387_bb0060","first-page":"F746","article-title":"Kinetics of monocyte 1 alpha-hydroxylase in renal failure","volume":"268","author":"Gallieni","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2010.387_bb0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/ajkd.2001.28582","article-title":"Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients","volume":"38","author":"Marco","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.387_bb0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.387_bb0075","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.387_bb0080","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.387_bb0085","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ki.2008.343","article-title":"Oral active vitamin D is associated with improved survival in hemodialysis patients","volume":"74","author":"Naves-Diaz","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.387_bb0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.387_bb0095","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2215\/CJN.01760408","article-title":"Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients","volume":"3","author":"Shinaberger","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.387_bb0100","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2010.387_bb0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","article-title":"Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse","volume":"103","author":"Simpson","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/ki.2010.387_bb0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.2008.101","article-title":"Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.387_bb0115","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","article-title":"Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals","volume":"104","author":"Bodyak","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2010.387_bb0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.ki.5002675","article-title":"The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats","volume":"73","author":"Lopez","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.387_bb0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2008.26","article-title":"Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification","volume":"73","author":"Lomashvili","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.387_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jsbmb.2005.06.013","article-title":"Mechanisms for the selective action of Vitamin D analogs","volume":"97","author":"Bouillon","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/ki.2010.387_bb0135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1038\/ki.2010.387_bb0140","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2010.387_bb0145","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI29449","article-title":"Resurrection of vitamin D deficiency and rickets","volume":"116","author":"Holick","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.387_bb0150","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nrneph.2009.143","article-title":"Transplantation: supplemental vitamin D: will do no harm and might do good","volume":"5","author":"Cunningham","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1038\/ki.2010.387_bb0155","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"10.1038\/ki.2010.387_bb0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2006060573","article-title":"Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency","volume":"18","author":"London","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815548709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815548709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T16:47:05Z","timestamp":1559753225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815548709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0085253815548709"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.387","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}